Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Recent & Breaking News (TSX:OPS)

Opsens - Announces Q1 2020 Results

Canada NewsWire January 13, 2020

Opsens Receives dPR Clearance from the FDA

Canada NewsWire December 19, 2019

Opsens - Record FY2019 Consolidated Revenues of $32.8 M, Up 36%, Record FFR Revenues of $20M, Up 41%

Canada NewsWire November 14, 2019

Opsens - First clinical use of OptoWire III after Health Canada approval

Canada NewsWire November 7, 2019

Opsens Announces Entry Into Structural Heart Market

Canada NewsWire November 5, 2019

Opsens Solutions - Strategic Order for Fiber Optic Sensors to be Deployed in New Industrial Dewatering Process

Canada NewsWire July 16, 2019

Opsens - Q3 2019 - Record Quarterly FFR Revenues of $5.2 M, Up 49%

Canada NewsWire July 11, 2019

UPDATE - Opsens Solutions Partners With Temai Ingenieros for the Commissioning of an Optical-Based Fuel Monitoring System for a Major Aircraft Manufacturer

GlobeNewswire June 17, 2019

Opsens Solutions Further Expands Intellectual Property Portfolio with USPTO Grant

Canada NewsWire June 11, 2019

Opsens Signs Landmark Supplier Agreement - Expands Optical Sensing Technology Impact Within Cardiology Segment

Canada NewsWire April 30, 2019

Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase

Canada NewsWire April 11, 2019

Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors

Canada NewsWire March 4, 2019

Opsens announces credit agreement with CIBC Innovation Banking

Canada NewsWire February 27, 2019

Opsens - Election results for the Board of directors

Canada NewsWire January 24, 2019

Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

Canada NewsWire January 14, 2019

Opsens' dPR obtains CE marking to sell in Europe

Canada NewsWire January 9, 2019

Opsens reports Q4 and FY2018 results

Canada NewsWire November 28, 2018

Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest

Canada NewsWire November 27, 2018

Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest

Canada NewsWire November 8, 2018

Opsens - 50,000 patients diagnosed with the OptoWire

Canada NewsWire November 1, 2018